Enteric fistula
Intestinal fistula refers to the appearance of a pathological channel between the intestines, between the intestines and other organs, or outside the body, which causes intestinal contents to flow out of the intestinal cavity, leading to a series of pathophysiological changes such as infection, fluid loss, malnutrition, and organ dysfunction.
-
Site of disease:
intestinal -
Infectious :
Not contagious -
Frequent population:
Surgery is common -
Related symptoms:
Stomach ache feces-like substance flowing out of the abdominal wound abdominal infection abdominal distension high fever -
Concurrent disease:
Related Drugs
Somatostatin for injection
Indication: Severe acute esophageal varicose bleeding. Severe acute gastric or duodenal ulcer bleeding, or complicated by acute erosive gastritis or hemorrhagic gastritis. Adjuvant treatment of pancreatic, biliary and intestinal fistulas. Prevention and treatment of complications after pancreatic surgery. Adjuvant treatment of diabetic ketoacidosis.
Somatostatin for injection
Indication: Severe acute esophageal varicose bleeding. Severe acute gastric or duodenal ulcer bleeding, or complicated by acute erosive gastritis or hemorrhagic gastritis. Adjuvant treatment of pancreatic, biliary and intestinal fistulas. Prevention and treatment of complications after pancreatic surgery. Adjuvant treatment of diabetic ketoacidosis.
Somatostatin for injection
Indication: Severe acute esophageal varicose bleeding. Severe acute gastric or duodenal ulcer bleeding, or complicated by acute erosive gastritis or hemorrhagic gastritis. Adjuvant treatment of pancreatic, biliary and intestinal fistulas. Prevention and treatment of complications after pancreatic surgery. Adjuvant treatment of diabetic ketoacidosis.
Somatostatin for injection
Indication: Severe acute esophageal varicose bleeding. Severe acute gastric or duodenal ulcer bleeding, or complicated by acute erosive gastritis or hemorrhagic gastritis. Adjuvant treatment of pancreatic, biliary and intestinal fistulas. Prevention and treatment of complications after pancreatic surgery. Adjuvant treatment of diabetic ketoacidosis.
Manufacturer:
Qingdao Guoda Biopharmaceutical Co., Ltd.
Enteral Nutrition Emulsion (TP)
Indication: This product is suitable for patients with malnutrition or dietary disorders of gastrointestinal function, including patients after trauma or craniofacial and cervical surgery; patients with difficulty chewing and swallowing; patients with unclear consciousness or receiving mechanical ventilation; patients who need nutritional supplements after surgery; patients with anorexia nervosa, etc. This product does not contain dietary fiber and can be used for patients with severe gastrointestinal stenosis; patients with intestinal fistula; and preoperative or pre-diagnosis intestinal preparation.
Enteral Nutrition Emulsion (TP)
Indication: This product is suitable for patients with malnutrition or dietary disorders of gastrointestinal function, including patients after trauma or craniofacial and cervical surgery; patients with difficulty chewing and swallowing; patients with unclear consciousness or receiving mechanical ventilation; patients who need nutritional supplements after surgery; patients with anorexia nervosa, etc. This product does not contain dietary fiber and can be used for patients with severe gastrointestinal stenosis; patients with intestinal fistula; and preoperative or pre-diagnosis intestinal preparation.
Related Ingredients
-
15-28-Somatostatin-28 list
38916-34-6 -
Α-protein list
146317-23-9 -
fatty acid list
9150-89-4